Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Frontiers in Oncology|January 3, 2022
Clonal Evolution of High-Risk Chronic Lymphocytic Leukemia: A Contemporary PerspectiveMarwan Kwok, Catherine J WuBlood|March 8, 2024
DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategiesMarwan Kwok, Angelo Agathanggelou, Tatjana StankovicBlood Cancer Discovery|January 11, 2022
Cancer and COVID-19: On the Quest for Effective VaccinesMarwan Kwok, Edward F Fritsch, Catherine J WuCancers|September 28, 2021
Targeting the p53 Pathway in CLL: State of the Art and Future PerspectivesMarwan Kwok, Angelo Agathanggelou, Nicholas Davies, et al.Cancers|January 21, 2022
Correction: Kwok et al. Targeting the p53 Pathway in CLL: State of the Art and Future Perspectives. Cancers 2021, 13, 4681Marwan Kwok, Angelo Agathanggelou, Nicholas Davies, et al.Lancet (London, England)|August 28, 2015
Synthetic lethality in chronic lymphocytic leukaemia with DNA damage response defects by targeting the ATR pathwayMarwan Kwok, Nicholas Davies, Angelo Agathanggelou, et al.Blood|October 5, 2016
Minimal residual disease is an independent predictor for 10-year survival in CLLMarwan Kwok, Andy C Rawstron, Abraham Varghese, et al.Blood|November 14, 2015
ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cellsMarwan Kwok, Nicholas Davies, Angelo Agathanggelou, et al.Oncotarget|May 13, 2017
Dynamic changes in clonal cytogenetic architecture during progression of chronic lymphocytic leukemia in patients and patient-derived murine xenograftsNicholas J Davies, Marwan Kwok, Clive Gould, et al.Frontiers in Immunology|January 11, 2020
Long-Term Ibrutinib Therapy Reverses CD8+ T Cell Exhaustion in B Cell Chronic Lymphocytic LeukaemiaHelen M Parry, Nikhil Mirajkar, Natasha Cutmore, et al.Pageof 2